Aramis Biosciences

Edit info

Founded: 2018

Location: Medfield, MA

Employee range: 1 - 10

Clinical stage: Clin2

Therapy area: Dry eye disease

Drug types: OPH, IMM

Lead product: A197

Funding: $10.5M A Dec 2021

aramisbio.com

linkedin.com

job board

Drug notes:

Also Clin0 immuno-inflammatory ocular disease

About:

Aramis Biosciences is concentrated on creating novel disease-modifying treatments for dry eye disease, which is highly undertreated. They are a Massachusetts-based clinical-stage biopharmaceutical company founded in 2018 by Harvard Professors Reza Dana and Sunil Chauhan with expertise in immunology and ophthalmology. Aramis plans to develop treatments for other ocular diseases as well.

Jobs:

Main

Contact: recruit@workinbiotech.com